← Back to Clinical Trials
Recruiting NCT07447505

NCT07447505 Effect of a High-Protein, High-Fiber Pre-Fast Meal on Satiety and Glycemic Profiles During Fasting

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07447505
Status Recruiting
Phase —
Sponsor King Faisal University
Condition Glycemic Response; Satiety
Study Type INTERVENTIONAL
Enrollment 38 participants
Start Date 2026-02-23
Primary Completion 2026-03-23

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
High-Protein, High-Fiber MealLow-Protein, Low-Fiber Meal

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 38 participants in total. It began in 2026-02-23 with a primary completion date of 2026-03-23.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This randomized crossover study investigates the effect of consuming a high-protein, high-fiber pre-fast meal on subjective satiety and glycemic responses during fasting hours in healthy adults. Participants will complete two dietary conditions in a randomized order: a standardized high-protein, high-fiber pre-fast meal and a low-protein, low-fiber pre-fast meal guided by dietary instructions. Each condition will be followed for two consecutive days and separated by a three-day washout period. Outcomes include subjective appetite sensations during fasting hours, glycemic profiles assessed using continuous glucose monitoring (CGM), and exploratory analyses examining the association between glucose dynamics and appetite sensations.

Eligibility Criteria

Inclusion Criteria: * Adults aged 18 years and older * Willingness to comply with study procedures, including fasting and continuous glucose monitoring * Ability to provide informed consent Exclusion Criteria: * Diagnosed diabetes mellitus or known metabolic disease * History of cardiovascular, gastrointestinal, or endocrine disorders that may affect study outcomes * Use of medications known to affect glucose metabolism or appetite * Pregnancy or lactation * Known allergy or intolerance to any study meal components (oats, dairy, peanuts, nuts, cranberries)

Contact & Investigator

Central Contact

Wafa Alotaibi

✉ Walotaibi@kfu.edu.sa

📞 +966500358622

Frequently Asked Questions

Who can join the NCT07447505 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Glycemic Response; Satiety. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07447505 currently recruiting?

Yes, NCT07447505 is actively recruiting participants. Contact the research team at Walotaibi@kfu.edu.sa for enrollment information.

Where is the NCT07447505 trial being conducted?

This trial is being conducted at Al-Ahsa, Saudi Arabia.

Who is sponsoring the NCT07447505 clinical trial?

NCT07447505 is sponsored by King Faisal University. The trial plans to enroll 38 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology